These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33305919)

  • 1. Insights on Kawasaki disease and multisystem inflammatory syndrome: relationship with COVID-19 infection.
    Calcaterra G; Mehta JL; Fanos V; Bassareo PP
    Minerva Pediatr (Torino); 2021 Jun; 73(3):203-208. PubMed ID: 33305919
    [No Abstract]   [Full Text] [Related]  

  • 2. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features.
    Rowley AH
    J Pediatr; 2020 Sep; 224():129-132. PubMed ID: 32585239
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
    Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
    Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
    Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
    Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIMS-TS and Kawasaki Disease: The Mystery Deepens.
    Lutchman D
    Pediatr Infect Dis J; 2020 Aug; 39(8):e215-e216. PubMed ID: 32675759
    [No Abstract]   [Full Text] [Related]  

  • 6. Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C.
    Mazori DR; Derrick KM; Kapoor U; Haribhai M; Gist RE; Glick SA
    Pediatr Dermatol; 2021 Jan; 38(1):253-256. PubMed ID: 33222290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisystem Inflammatory Syndrome Associated With Coronavirus Disease in Children: A Multi-centered Study in Belém, Pará, Brazil.
    de Farias ECF; Pedro Piva J; de Mello MLFMF; do Nascimento LMPP; Costa CC; Machado MMM; Rodrigues TDS; Carvalho RDFP; Alves MCB; Aires LFQ; Cotta MLM; Pedreira ARG; Saraty SB; Lima MC; Justino MCA
    Pediatr Infect Dis J; 2020 Nov; 39(11):e374-e376. PubMed ID: 32826724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Artery Changes in Patients with Multisystem Inflammatory Syndrome in Children: Los Angeles Experience.
    Pick J; Rao MY; Dern K; Wang S; Szmuszkovicz J; Wagner-Lees S; Badran S; Wong PC; Votava-Smith JK
    J Pediatr; 2022 Jan; 240():292-296. PubMed ID: 34560093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric multisystem inflammatory syndrome associated with COVID-19: filling the gap between myocarditis and Kawasaki?
    Bordet J; Perrier S; Olexa C; Gerout AC; Billaud P; Bonnemains L
    Eur J Pediatr; 2021 Mar; 180(3):877-884. PubMed ID: 32959075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What do we know about Kawasaki disease and COVID-19?].
    Hernandez Arias JJWA; Herrera de la Hoz RE; Lequerica Segrera PL
    Andes Pediatr; 2021 Apr; 92(2):281-287. PubMed ID: 34106169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same.
    García-Salido A; Cuenca-Carcelén S; Castillo-Robleda A
    Med Clin (Barc); 2021 Jan; 156(2):89-91. PubMed ID: 33160625
    [No Abstract]   [Full Text] [Related]  

  • 12. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
    Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
    Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisystem inflammatory syndrome in children (MIS-C) without antecedent clinical symptoms related to COVID-19: The increasing importance of distinguishing MIS-C in patients with Kawasaki disease-like features.
    Ozaki M; Hori T; Miwa Y; Yamamoto T; Kubota K; Kawamoto M; Kawamoto N; Ohnishi H
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):202-204. PubMed ID: 35106599
    [No Abstract]   [Full Text] [Related]  

  • 14. Multisystem inflammatory syndrome in children with Kawasaki disease-like manifestations in MMA.
    Huang M; Lu X; Zeng Y; Wang W; Zhang J; Wang L; Dong G
    Endokrynol Pol; 2024; 75(2):230-231. PubMed ID: 38497373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvasculature dysfunction as the common thread between atherosclerosis, Kawasaki disease, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated multi-system inflammatory syndrome in children.
    Boyle EC; Haverich A
    Eur J Cardiothorac Surg; 2020 Dec; 58(6):1109-1110. PubMed ID: 33247736
    [No Abstract]   [Full Text] [Related]  

  • 16. A dermatologic perspective on multisystem inflammatory syndrome in children.
    Naka F; Melnick L; Gorelik M; Morel KD
    Clin Dermatol; 2021; 39(1):163-168. PubMed ID: 33972046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: A Spectrum of Postinfectious Hyperinflammatory Disease.
    Robinson LA; Dale M; Gorelik M
    Rheum Dis Clin North Am; 2023 Aug; 49(3):661-678. PubMed ID: 37331739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
    Yang MC; Tsai CC; Su YT; Wu JR
    Kaohsiung J Med Sci; 2021 Mar; 37(3):255-256. PubMed ID: 33400372
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronavirus disease 2019-associated multisystem inflammatory syndrome and Kawasaki disease.
    Uejima Y; Suganuma E; Matsunaga K; Kitajima I; Niimi H
    Pediatr Int; 2022 Jan; 64(1):e15349. PubMed ID: 36348517
    [No Abstract]   [Full Text] [Related]  

  • 20. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
    Bukulmez H
    Curr Rheumatol Rep; 2021 Jul; 23(8):58. PubMed ID: 34216296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.